CliffBio
small molecule

ZOSYN IN PLASTIC CONTAINER

PIPERACILLIN SODIUM; TAZOBACTAM SODIUM

Loss of exclusivity—loss of exclusivity
CompanyBaxter Healthcare Corp →See this company's full patent-cliff portfolio

Drug detail

Brand nameZOSYN IN PLASTIC CONTAINER
Active ingredientPIPERACILLIN SODIUM; TAZOBACTAM SODIUM
StrengthEQ 40MG BASE/ML;EQ 5MG BASE/ML
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalFebruary 1998
Marketing statusRX

More from Baxter Healthcare Corp

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.